Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19

The present Perspective examined the latest evidence on the association between the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the incidence/mortality of coronavirus disease 2019 (COVID‐19). Our critical appraisal from existing literature does...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Martin C.S., Wong, Sunny, Huang, Junjie, Yan, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524232/
https://www.ncbi.nlm.nih.gov/pubmed/33121220
http://dx.doi.org/10.1002/ehf2.12952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524232/
https://www.ncbi.nlm.nih.gov/pubmed/33121220
http://dx.doi.org/10.1002/ehf2.12952

Ejemplares similares